Health Care

Merck says experimental RSV treatment protected infants in trial, paving way for potential approval

Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.

adminadmin
Oct 18, 2024 - 07:00
 0  10
Merck says experimental RSV treatment protected infants in trial, paving way for potential approval
Merck is discussing the study data with regulators worldwide, with a goal of making the treatment available for infants as early as the 2025 to 2026 RSV season.
Read More

Tags:

Previous Article

Crude oil prices rise slightly after four-day losing streak

Next Article

August business inventories post in line with estimates; Homebuilder sentiment r...

admin
admin

Related Posts

We're encouraged by an activist's willingness to buy an Abbott rival, look past baby formula suits

We're encouraged by an activist's willingness to buy an...

admin May 22, 2024  0  16

Healthy Returns: AstraZeneca expands U.S. investment plan on confidence in economy

Healthy Returns: AstraZeneca expands U.S. investment pl...

admin Nov 13, 2024  0  10

Neuralink competitor Paradromics gears up to test its brain implant on humans

Neuralink competitor Paradromics gears up to test its b...

admin Jun 22, 2024  0  10